← Back
$HRMY All transactions

Harmony Biosciences Holdings, Inc.

▼ SELL 10b5-1 Plan

$ Value

$238K

Shares

5,933

Price

$40

Filed

Dec 17

Insider

Name

Dayno Jeffrey M.

Title

PRESIDENT, CEO

CIK

0001615993

Roles

Director Officer

Transaction Details

Transaction Date

2025-12-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.28. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | The stock option vests in five equal annual installments beginning on November 1, 2018.

Filing Info

Accession No.

0001615993-25-000005

Form Type

4

Issuer CIK

0001802665

Dayno Jeffrey M.'s History

Date Ticker Type Value
2026-01-25 HRMY M $0
2026-01-25 HRMY F $208K
2026-01-25 HRMY M $0
2026-01-24 HRMY M $0
2026-01-24 HRMY F $176K
2026-01-24 HRMY M $0
2026-01-22 HRMY A $0
2026-01-22 HRMY A $0
2025-12-12 HRMY M $164K
2025-12-12 HRMY $802K

Other Insiders at HRMY (90d)

Insider Bought Sold Last
Ignelzi Troy A. 2026-04-02
Dayno Jeffrey M.
PRESIDENT, CEO
2026-01-25
Kapadia Sandip
CHIEF FINANCIAL OFFICER
$139K 2026-01-26
Serafin Andrew
CHIEF STRATEGY OFFICER
2026-01-25
Anastasiou Peter
CHIEF OPERATING OFFICER
2026-04-02
Budur Kumar
CHIEF MEDICAL OFFICER
2026-01-25
Zaeske Adam H.
CHIEF COMMERCIAL OFFICER
2026-04-07